GlaxoSmithKline agreed Friday to pay Louisiana $45 million to settle lawsuits accusing it of improperly marketing the diabetes drug Avandia and other drugs.
.
Drugmaker agrees to $45M settlement with Louisiana
GlaxoSmithKline agreed Friday to pay Louisiana $45 million to settle lawsuits accusing it of improperly marketing the diabetes drug Avandia and other drugs.
There are currently 1 users browsing this thread. (0 members and 1 guests)
Posting Permissions
Quote